Obesity and Insulin Resistance Are the Main Determinants of Postprandial Lipoprotein Dysmetabolism in Polycystic Ovary Syndrome

Table 5

Postprandial TG, HDL, apoB-48, glucose, and insulin levels adjusted for BMI, , and .

	Covariate: BMI		Covariate: HOMAIR		Covariate:
	PCOS	Controls	PCOS	Controls	PCOS	Controls
TG 0 hrs (mmol/L)	1.54 ± 0.13	1.25 ± 0.12	1.40 ± 0.11	1.36 ± 0.11	1.47 ± 0.13	1.33 ± 0.14
TG 2 hrs (mmol/L)	2.14 ± 0.16	1.66 ± 0.16	1.97 ± 0.14	1.79 ± 0.14	2.04 ± 0.17	1.73 ± 0.18
TG 4 hrs (mmol/L)	2.37 ± 0.20	1.90 ± 0.19	2.14 ± 0.16	2.10 ± 0.16	2.24 ± 0.20	2.10 ± 0.22
TG 6 hrs (mmol/L)	1.92 ± 0.21	1.57 ± 0.21	1.70 ± 0.18	1.75 ± 0.18	1.80 ± 0.22	1.77 ± 0.24
TG 8 hrs (mmol/L)	1.71 ± 0.19	1.37 ± 0.19	1.48 ± 0.16	1.56 ± 0.16	1.60 ± 0.20	1.56 ± 0.22
AUC-TG (mmol/L⋅8 hrs)	8.06 ± 0.68	6.45 ± 0.66	7.25 ± 0.54	7.10 ± 0.54	7.61 ± 0.70	7.04 ± 0.76
iAUC-TG (mmol/L⋅8 hrs)	1.87 ± 0.29	1.45 ± 0.29	1.63 ± 0.27	1.65 ± 0.27	1.64 ± 0.31	1.82 ± 0.33
HDL-chol 0 hrs (mmol/L)	1.40 ± 0.06	1.45 ± 0.06	1.41 ± 0.06	1.44 ± 0.06	1.40 ± 0.06	1.38 ± 0.07
HDL-chol 2 hrs (mmol/L)	1.33 ± 0.06	1.38 ± 0.06	1.34 ± 0.05	1.37 ± 0.05	1.34 ± 0.06	1.33 ± 0.07
HDL-chol 4 hrs (mmol/L)	1.27 ± 0.06	1.32 ± 0.05	1.28 ± 0.05	1.31 ± 0.05	1.28 ± 0.06	1.27 ± 0.06
HDL-chol 6 hrs (mmol/L)	1.30 ± 0.06	1.37 ± 0.06	1.32 ± 0.06	1.36 ± 0.06	1.31 ± 0.06	1.31 ± 0.07
HDL-chol 8 hrs (mmol/L)	1.35 ± 0.06	1.38 ± 0.06	1.36 ± 0.06	1.37 ± 0.06	1.36 ± 0.06	1.32 ± 0.07
AUC-HDL-chol (mmol/L⋅8 hrs)	5.28 ± 0.23	5.49 ± 0.22	5.33 ± 0.22	5.44 ± 0.22	5.31 ± 0.24	5.26 ± 0.26
iAUC-HDL-chol (mmol/L⋅8 hrs)	−0.33 ± 0.06	−0.31 ± 0.06	−0.33 ± 0.06	−0.32 ± 0.06	−0.30 ± 0.06	−0.27 ± 0.07
ApoB-48 0 hrs (μg/mL)	12.4 ± 1.54	9.70 ± 1.47	11.9 ± 1.49	9.86 ± 1.46	11.9 ± 1.70	10.4 ± 1.80
ApoB-48 2 hrs (μg/mL)	17.3 ± 1.43	15.6 ± 1.36	17.0 ± 1.37	15.7 ± 1.34	16.5 ± 1.53	16.9 ± 1.62
ApoB-48 4 hrs (μg/mL)	19.6 ± 1.77	15.5 ± 1.69	19.8 ± 1.68	15.2 ± 1.64	19.2 ± 1.90	16.8 ± 2.00
ApoB-48 6 hrs (μg/mL)	18.9 ± 2.06	15.6 ± 1.97	17.2 ± 1.94	16.9 ± 1.90	17.9 ± 2.22	17.5 ± 2.34
ApoB-48 8 hrs (μg/mL)	13.2 ± 1.60	11.2 ± 1.53	11.7 ± 1.47	12.4 ± 1.44	12.3 ± 1.70	12.5 ± 1.79
Log ApoB-48 (μg/mL⋅8 hrs)	67.8 ± 5.51	57.1 ± 5.26	65.6 ± 5.30	58.4 ± 5.18	65.0 ± 5.97	62.5 ± 6.30
iAUC apoB-48 (μg/mL⋅8 hrs)	19.02 ± 3.33	18.31 ± 3.18	17.57 ± 3.19	19.98 ± 3.12	17.92 ± 3.70	21.06 ± 3.91
Insulin 0 hrs (pmol/L)	17.9 ± 1.56	13.4 ± 1.2	15.4 ± 0.30	15.6 ± 0.30	17.5 ± 1.66	15.1 ± 1.79
Insulin 2 hrs (pmol/L)	95.7 ± 10.3	59.5 ± 10.1	88.7 ± 8.91	63.8 ± 8.91	91.6 ± 11.3	64.1 ± 12.2
Insulin 4 hrs (pmol/L)	47.6 ± 5.59	24.6 ± 5.47	43.7 ± 4.92	27.6 ± 4.92	45.7 ± 5.94	27.7 ± 6.42
Insulin 6 hrs (pmol/L)	20.9 ± 1.90	11.6 ± 1.86	19.2 ± 1.57	12.9 ± 1.57	19.9 ± 1.94	13.2 ± 2.11
Insulin 8 hrs (pmol/L)	13.6 ± 1.89	14.4 ± 1.84	13.4 ± 1.81	14.3 ± 1.81	14.1 ± 2.17	14.7 ± 2.35
AUC-insulin (pmol/L⋅8 hrs)	180 ± 16.2	110 ± 15.8	166 ± 13.0	119 ± 13.0	173 ± 17.5	120 ± 18.9
iAUC-insulin (pmol/L⋅8 hrs)	108 ± 13.5	55.9 ± 13.2	104 ± 13.0	57.0 ± 13.0	103 ± 14.7	59.6 ± 15.9

ANCOVA analysis after log transformation. versus controls. versus controls.